PortfoliosLab logoPortfoliosLab logo
IPO Date
Mar 5, 2021

Highlights

Market Cap
$56.59M
Enterprise Value
$276.46M
EPS (TTM)
-$35.56
Total Revenue (TTM)
$30.25M
Gross Profit (TTM)
$18.07M
EBITDA (TTM)
-$352.83M
Year Range
$2.62 - $21.34
ROA (TTM)
-110.28%
ROE (TTM)
193.71%
Avg. Volume (1M)
211K
Avg. Volume Value (1M)
$1.72M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

SCLX Performance Chart

Scilex Holding Company (SCLX) is down 12.3% since the beginning of the year. At $7 per share, SCLX is trading 68.8% below its 52-week high of $21. Investors who bought $1,000 worth of SCLX shares 5 years ago would now be looking at an investment worth $31.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Scilex Holding Company (SCLX) has returned -12.26% so far this year and -20.18% over the past 12 months.


Scilex Holding Company

1D
0.98%
1M
-14.66%
6M
25.63%
YTD
-12.26%
1Y
-20.18%
3Y*
-61.16%
5Y*
-50.18%
10Y*
ALL TIME*
-47.40%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SCLX Monthly Returns History

Based on dividend-adjusted daily data since Mar 5, 2021, SCLX's average daily return is -0.02%, while the average monthly return is -0.34%.

Historically, 51% of months were positive and 49% were negative. The best month was Jul 2025 with a return of +127.8%, while the worst month was Nov 2022 at -56.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SCLX closed higher 42% of trading days. The best single day was Apr 5, 2023 with a return of +56.6%, while the worst single day was Mar 1, 2024 at -41.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-30.16%-3.64%-18.88%57.96%-15.40%40.75%-14.55%-12.26%
2025-3.40%-42.70%5.30%-45.50%8.02%15.04%127.84%32.34%10.81%-16.16%23.39%-40.08%-18.25%
2024-19.61%38.41%-29.96%-46.34%26.58%78.70%-17.62%-27.67%-19.60%3.86%-32.94%-33.79%-79.10%
202397.74%9.63%-5.20%-11.71%-17.82%-6.39%-1.80%-47.53%-51.22%33.57%-33.16%63.20%-48.87%
20220.50%0.40%0.49%-0.00%0.29%0.10%0.78%0.39%-0.10%0.87%-56.80%-11.35%-60.26%
20210.30%0.61%-0.40%0.20%0.40%0.20%0.20%0.20%0.30%-0.11%1.93%

Benchmark Metrics

Scilex Holding Company has an annualized alpha of -11.57%, beta of 0.49, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 05, 2021.

  • This stock participated in 239.53% of S&P 500 Index downside but only 15.57% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.49 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-11.57%
Beta
0.49
0.01
Upside Capture
15.57%
Downside Capture
239.53%

Return for Risk

Risk / Return Rank

SCLX ranks 41 for risk / return — above 41% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.


SCLX Risk / Return Rank: 4141
Overall Rank
SCLX Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SCLX Sortino Ratio Rank: 4848
Sortino Ratio Rank
SCLX Omega Ratio Rank: 4646
Omega Ratio Rank
SCLX Calmar Ratio Rank: 3636
Calmar Ratio Rank
SCLX Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Scilex Holding Company (SCLX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SCLXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.59

Sortino ratioReturn per unit of downside risk

-1.40

Omega ratioGain probability vs. loss probability

1.07

1.25

-0.19

Calmar ratioReturn relative to maximum drawdown

-0.25

2.00

-2.26

Martin ratioReturn relative to average drawdown

-0.35

8.49

-8.84

Dividends

Dividend History


Scilex Holding Company doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Scilex Holding Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Scilex Holding Company was 99.23%, occurring on Apr 22, 2025. The portfolio has not yet recovered.

The current Scilex Holding Company drawdown is 97.93%.


Drawdown

Fall

Recovery

Underwater

Related event

-99.23%Apr 2025
2y 10d
3y 3moApr 2023 - now
2025 selloff2025
-72.67%Dec 2022
1mo 18d23d
2mo 11dNov 2022 - Jan 2023
Bear market2022
-42.23%Jan 2023
1d2mo 11d
2mo 12dJan 2023 - Apr 2023
-16.08%Nov 2022
8d4d
12dOct 2022 - Nov 2022
Bear market2022
-8.13%Apr 2023
1d1d
1dApr 2023 - Apr 2023

Drawdown Indicators


SCLXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.23%

-56.78%

-42.45%

Max Drawdown (1Y)

Largest decline over 1 year

-80.27%

-9.10%

-71.17%

Max Drawdown (3Y)

Largest decline over 3 years

-98.19%

-18.90%

-79.29%

Max Drawdown (5Y)

Largest decline over 5 years

-99.23%

-25.43%

-73.80%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-97.93%

-1.58%

-96.35%

Average Drawdown

Average peak-to-trough decline

-57.92%

-10.70%

-47.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.55%

2.14%

+55.41%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Scilex Holding Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Scilex Holding Company is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SCLX relative to other companies in the Drug Manufacturers - General industry. Currently, SCLX has a P/S ratio of 2.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with SCLX

Add Scilex Holding Company to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with SCLX